Humacyte HUMA
NASDAQ HUMA
$0.57 0.00 (-0.86%)
As of: Sep 10, 2026 · 2:07 PM EDT

Humacyte (HUMA) EPS (Diluted) (2020 - 2026)

Analysis

Humacyte (HUMA) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Krystal Biotech 10.22 Bn 9.38 Bn 112.79 Mn 1.79
2 CRISPR Therapeutics AG 5.03 Bn 5.03 Bn - -0.94
3 Iovance Biotherapeutics 3.65 Bn 3.35 Bn 55.72 Mn -0.11
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 0.42
5 uniQure 2.99 Bn 2.99 Bn 5.49 Mn -1.22
6 Beam Therapeutics 2.52 Bn 2.52 Bn - -1.18
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 0.05
8 Sarepta Therapeutics 2.14 Bn 1.35 Bn 251.87 Mn -0.05
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 0.04
10 Humacyte 134.44 Mn 134.44 Mn -825,000.00 -0.12
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.12
Mar 31, 2026 -0.16
Dec 31, 2025 -0.21
Sep 30, 2025 -0.17
Jun 30, 2025 -0.20
Mar 31, 2025 -0.19
Dec 31, 2024 -0.25
Sep 30, 2024 -0.27
Jun 30, 2024 -0.26
Mar 31, 2024 -0.25
Dec 31, 2023 -0.26
Sep 30, 2023 -0.24
Jun 30, 2023 -0.26
Mar 31, 2023 -0.22
Dec 31, 2022 -0.20
Sep 30, 2022 -0.24
Jun 30, 2022 -0.19
Mar 31, 2022 -0.23
Dec 31, 2021 -0.58
Sep 30, 2021 -0.72